Sotera Health SHC Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 55.3%-0.2pp | 55.5%-0.5pp | 56%+0.5pp | 55.5%+0.4pp | 55.2%+0.4pp | |
| Net margin | 9.9%+3.2pp | 6.7%+1.9pp | 4.8%+2.7pp | 2.1%-0.1pp | 2.2%-1.8pp | |
| EBITDA margin | 15.3%+4.3pp | 11%-5.3pp | 16.3%-5.8pp | 22.2%-9.7pp | 31.9%-10.0pp | |
| Free cash flow margin | 8.1%-4.7pp | 12.8%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | 22.7%+7.3pp | 15.4%+4.6pp | 10.9%+5.7pp | 5.1%-0.7pp | 5.9%-4.6pp | |
| Return on assets | 3.7%+1.3pp | 2.5%+0.7pp | 1.7%+1.0pp | 0.8%0.0pp | 0.8%-0.6pp | |
| Return on invested capital | 1.3%+1.4pp | -0.2%-1.0pp | 0.9%-0.9pp | 1.8%-2.0pp | 3.8%-2.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 9×-1.0× | 10×+0.2× | 9.8×+1.3× | 8.5×-0.3× | 8.8×-1.4× | |
| Liquidity | ||||||
| Current ratio | 2.8×+0.4× | 2.5×+0.1× | 2.4×-0.1× | 2.5×0.0× | 2.5×-0.3× | |
| Quick ratio | 2.5×+0.3× | 2.2×+0.1× | 2.2×0.0× | 2.2×0.0× | 2.2×-0.3× | |
| Cash ratio | 1.5×+0.1× | 1.4×+0.1× | 1.2×-0.1× | 1.3×0.0× | 1.3×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 3.6×-0.1× | 3.8×-0.4× | 4.1×-0.5× | 4.6×-1.1× | 5.7×-0.1× | |
| Debt-to-assets | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.8×0.0× | |
| Net debt / EBITDA | 10.7×-4.3× | 15×+4.5× | 10.5×+2.4× | 8.1×+2.3× | 5.8×+1.3× | |
| Per Share | ||||||
| Book value per share | $2.16+2.3% | $2.12+10.2% | $1.92+7.3% | $1.79+22.5% | $1.46+2.8% | |
| Valuation | ||||||
| Market capitalization | $4.08B-18.6% | $5.01B+12.2% | $4.47B+40.0% | $3.19B-3.5% | $3.31B-14.7% | |
| Enterprise value | $6.03B-13.1% | $6.94B+7.7% | $6.45B+23.8% | $5.21B-2.6% | $5.35B-10.1% | |
| Price / earnings | 34.6×-29.7× | 64.3×-16.3× | 80.6×-52.2× | 132.8×-0.4× | 133.2×+45.9× | |
| Price / sales | 3.4×-0.9× | 4.3×+0.4× | 3.9×+1.0× | 2.8×-0.1× | 3×-0.5× | |
| Price / book | 6.6×-1.7× | 8.3×+0.2× | 8.1×+1.9× | 6.2×-1.7× | 8×-1.6× | |
| EV / EBITDA | 33.1×-20.9× | 54×+19.7× | 34.3×+13.4× | 20.9×+5.7× | 15.2×+2.3× | |
| EV / sales | 5.1×-0.9× | 6×+0.4× | 5.6×+1.0× | 4.6×-0.2× | 4.8×-0.6× | |
| Free cash flow yield | 2.4%-0.6pp | 3%— | —— | —— | —— | |
| Earnings yield | 2.9%+1.3pp | 1.6%+0.3pp | 1.2%+0.5pp | 0.8%0.0pp | 0.8%-0.4pp | |
| PEG ratio | 0.1×-0.8× | 0.9×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Sotera Health's profit margins?
- Sotera Health (SHC) runs a 55.3% gross margin and a 27.0% operating margin, with a 9.9% net margin.
- Where do Sotera Health's ratios come from?
- Every ratio is computed from Sotera Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.